# A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

> **NCT00947674** · PHASE4 · TERMINATED · sponsor: **Asahi Kasei Medical Co., Ltd.** · enrollment: 52 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DEVICE:** Cellsorba EX

## Key facts

- **NCT ID:** NCT00947674
- **Lead sponsor:** Asahi Kasei Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-10
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** short of enrollment
- **Last updated:** 2012-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947674, "A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00947674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*